13F Holdings
中文EN

SNN SMITH & NEPHEW PLC IFRS Annual reports only

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 845982 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY6.1%
TTM net income YoY51.7%
TTM EPS YoY52.3%
Revenue 3-yr CAGR5.7%
Net income 3-yr CAGR41.0%

Margins

Gross margin68.0%
Operating margin12.9%
Net margin10.1%
FCF margin—
EBITDA margin—

Returns

ROE11.8%
ROA6.0%
ROIC (approx.)13.6%
Asset turnover0.59x

Leverage & solvency

Liabilities / assets49.4%
Debt / equity0.00x
Current ratio2.57x
Interest coverage5.67x

Cash quality & payout

Operating cash flow / net income2.06x
Accruals ratio-6.3%
Payout ratio52.8%
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY2025*2025-12-31FY2024*2024-12-31FY2023*2023-12-31FY2022*2022-12-31FY2021*2021-12-31
Income statement
Revenue$6.16B$5.81B$5.55B$5.21B$5.21B
Cost of revenue$1.97B$1.76B$1.73B$1.54B$1.54B
Gross profit$4.19B$4.05B$3.82B$3.67B$3.67B
R&D expense$296.00M$289.00M$339.00M$345.00M$356.00M
SG&A expense$3.10B$3.10B$3.06B$2.88B$2.72B
Operating income$794.00M$657.00M$425.00M$450.00M$593.00M
Interest expense$140.00M$145.00M$132.00M$80.00M$80.00M
Pretax income$779.00M$498.00M$290.00M$235.00M$586.00M
Income tax$154.00M$86.00M$27.00M$12.00M$62.00M
Net income$625.00M$412.00M$263.00M$223.00M$524.00M
EPS (basic)0.720.470.300.260.60
EPS (diluted)0.720.470.300.260.60
Weighted avg. shares (diluted)873.00M876.00M873.00M873.00M878.00M
Banking
Net interest income-$112.00M-$121.00M-$98.00M-$66.00M-$74.00M
Balance sheet
Cash & equivalents$557.00M$619.00M$302.00M$350.00M$1.28B
Receivables$1.41B$1.38B$1.30B$1.26B$1.18B
Inventory$2.12B$2.39B$2.40B$2.21B$1.84B
Current assets$4.10B$4.42B$4.03B$3.86B$4.42B
PP&E, netmay include right-of-use assets (IFRS)$1.64B$1.42B$1.47B$1.46B$1.51B
Goodwill$3.11B$3.03B$2.99B$3.03B$2.99B
Intangibles$882.00M$1.03B$1.11B$1.24B$1.40B
Total assets$10.46B$10.35B$9.99B$9.97B$10.92B
Current liabilities$1.59B$1.53B$2.27B$1.72B$2.13B
Short-term debt$83.00M$2.00M$710.00M$111.00M$435.00M
Total liabilities$5.17B$5.09B$4.77B$4.71B$5.35B
Shareholders' equity$5.29B$5.26B$5.22B$5.26B$5.57B
Cash flow statement
Operating cash flow$1.28B$987.00M$608.00M$468.00M$877.00M
Investing cash flow-$406.00M-$569.00M-$448.00M-$472.00M-$691.00M
Financing cash flow-$955.00M-$86.00M-$200.00M-$926.00M-$645.00M
Stock-based compensation$43.00M$40.00M$39.00M$40.00M$41.00M
Dividends paid$330.00M$327.00M$327.00M$327.00M$329.00M
Share buybacks$502.00M——$158.00M—

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.